Skip to content
Risankizumab for Ulcerative Colitis episode artwork

Jul 22, 2024 15 min

Risankizumab for Ulcerative Colitis

from Healthy Dialogue

Ulcerative colitis can significantly decrease quality of life. A third of patients have persistent symptoms with tumor necrosis factor inhibitors and nearly 1 in 5 patients will be hospitalized within 5 years of diagnosis. Author Gilaad G. Kaplan, MD, MPH, of the University of Calgary joins JAMA Associate Editor John M. Inadomi, MD, to discuss Risankizumab for Ulcerative Colitis. Related Content: Monoclonal Antibody Risankizumab for Ulcerative Colitis Risankizumab for Ulcerative Colitis

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Risankizumab for Ulcerative Colitis

0:00 15:49

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Healthy Mind, Healthy Life Avik Chakraborty Welcome to Healthy Mind By Avik ™ - ”Healthy Mind, Healthy Life”, a podcast that explores the connection between mental health and overall well-being. Join us each week as we delve into topics related to positive psychology, mindfulness, and personal development, and provide practical tips and strategies for cultivating a healthy and balanced mind.Want to be a guest on Healthy Mind, Healthy Life? Send Avik a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/avik

Frequently asked questions

How long is this episode of Healthy Dialogue?

This episode is 15 minutes long.

When was this Healthy Dialogue episode published?

This episode was published on July 22, 2024.

Can I download this Healthy Dialogue episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.